NCT00026533 2017-06-06Thalidomide in Treating Patients With Thyroid CancerUniversity of KentuckyPhase 2 Completed
NCT00027638 2013-06-18Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsMemorial Sloan Kettering Cancer CenterPhase 2 Completed
NCT00165230 2009-04-28Thalidomide in Combination With Temodar in Patients With Neuroendocrine TumorsDana-Farber Cancer InstitutePhase 2 Completed32 enrolled